NGF and early-onset autosomal dominant Alzheimer disease: Nerve growth factor (NGF) has emerged as a potential therapeutic agent in Alzheimer’s disease (AD) due to its regenerative effects on basal forebrain cholinergic neurons (Williams et al., 2006; Mufson et al., 2008).